An Unbiased View of Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic outcomes stem from its conversation with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors within the central anxious system, conolidine modulates alternate molecular targets. A Science Improvements research observed that conolidine interacts Along with the atypical chemokine receptor ACKR3